Erik Bork se dedica al oficio de escribir, guiando a los aspirantes a creadores en el descubrimiento y desarrollo de sus ideas. Su trabajo como guionista y productor demuestra una profunda comprensión de la narración, perfeccionada a través de una amplia experiencia en televisión y cine. El enfoque de Bork enfatiza los elementos centrales de una narrativa viable, ofreciendo a los lectores herramientas prácticas para sus propios viajes creativos. A través de su enseñanza y recursos en línea, actúa como un valioso mentor en el arte de escribir para pantalla, escenario y ficción.
Multiple Emmy Award-winning screenwriter Erik Bork (HBO's BAND OF BROTHERS) presents the seven fundamental characteristics of a great story in any medium. Writers tend to jump into the writing too quickly, without knowing they have a flawed central idea. This book is all about ensuring that doesn't happen!
An overwhelming volume of previous studies have found that the majority of all mergers fail to meat their expected financial targets because of an inability to effectively integrate the organizations. Most companies are not ready to handle the large and complex task of merger integration, which often encompasses all areas of the organizations. Inability to prioritize and effectively execute the right processes in the merger integration effort can lead to stalemate in the company’s operation, which can have disastrous effects. While there have been numerous research made on specific areas of the integration process, the authors found no general framework that focuses on assessing merger integration capability at a company. This book utilizes a large volume of previous research and structures the identified best practises into a framework for success in all aspects of the merger integration process. Accompanied by a checklist it is possible to evaluate a company’s readiness for integration based on previous experiences, and highlight its main problem areas. This book also contains a real case study where the framework and checklist was applied in an evaluation of Biotage AB, a Swedish medical company on the Nordic Stock Exchange. The primary target group for this study is professionals dealing with merger integration, both consultants and organizations.